Kingsley Stuart A 4

What Happened Stuart A. Kingsley, a director of Indivior Pharmaceuticals, was granted 6,518 restricted stock units (RSUs) on 2026-05-13. The grant is reported at $0.00 per share in the Form 4 (transaction code A), meaning no cash was exchanged at grant; the RSUs represent a contingent right to receive one share each upon vesting.

Key Details

• Transaction date: 2026-05-13; filing date: 2026-05-14 (timely).
• Grant: 6,518 RSUs; reported price $0.00; reported dollar value $0 at grant.
• Vesting: RSUs vest on the day immediately preceding the date of the issuer's next annual meeting, subject to continued service (per footnote).
• Shares owned after transaction: Not disclosed in the filing.
• Transaction code: A = Award/Grant. No 10b5-1 plan, tax withholding, or late-filing flags noted in the filing.

Context RSU grants to directors are a common form of compensation and become meaningful only if and when they vest and convert to common shares. Because these units vest based on continued service and the annual meeting timing, they are not immediately tradable and do not by themselves indicate the director’s view on the company’s near-term share price.